search
Back to results

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

Primary Purpose

Vulvar Dysplasia, Vaginal Dysplasia

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
CO2 laser surgery
ultrasonic surgical aspiration
Sponsored by
University Hospitals Cleveland Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Vulvar Dysplasia focused on measuring ultrasonic surgical aspiration, CO2 laser surgery, vulvar dysplasia, vaginal dysplasia, recurrence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who present with vulvar or vaginal dysplasias or condylomas that require surgical intervention will be informed of the study by the treating physician
  • Pre-operative biopsies to confirm presence of dysplasia / condyloma. Patients with dysplasias of grade 3 / CIS will be included at the discretion of the treating surgeon and will have had invasion confidently excluded by clinical exam and biopsy.

Exclusion Criteria:

  • Patients under the age of eighteen or who are pregnant will be excluded

Sites / Locations

  • University Hospitals of Cleveland

Outcomes

Primary Outcome Measures

recurrence rate

Secondary Outcome Measures

pain
side effects
complications

Full Information

First Posted
October 30, 2006
Last Updated
May 6, 2022
Sponsor
University Hospitals Cleveland Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00394758
Brief Title
A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia
Official Title
Comparison of Surgical Procedures in Vulvar and Vaginal Dysplasias
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
January 1, 2000 (Actual)
Primary Completion Date
December 31, 2005 (Actual)
Study Completion Date
December 31, 2005 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospitals Cleveland Medical Center

4. Oversight

5. Study Description

Brief Summary
To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias To compare healing related complications, post-operative pain, and scarring between the two procedures.
Detailed Description
First line of treatment for vulvar intraepithelial neoplasia (VIN) and vaginal intraepithelial neoplasia (VAIN) is not well defined. Laser vaporization and ultrasonic surgical aspiration are both accepted surgical modalities used in the treatment of vulvar and vaginal dysplasias, however no prospective study has been done to compare the two procedures. The specific aims of this research study include: To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias in a prospective, multi-institutional, randomized clinical trial. To compare healing related complications, post-operative pain, and scarring between the two procedures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vulvar Dysplasia, Vaginal Dysplasia
Keywords
ultrasonic surgical aspiration, CO2 laser surgery, vulvar dysplasia, vaginal dysplasia, recurrence

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
CO2 laser surgery
Intervention Type
Procedure
Intervention Name(s)
ultrasonic surgical aspiration
Primary Outcome Measure Information:
Title
recurrence rate
Secondary Outcome Measure Information:
Title
pain
Title
side effects
Title
complications

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who present with vulvar or vaginal dysplasias or condylomas that require surgical intervention will be informed of the study by the treating physician Pre-operative biopsies to confirm presence of dysplasia / condyloma. Patients with dysplasias of grade 3 / CIS will be included at the discretion of the treating surgeon and will have had invasion confidently excluded by clinical exam and biopsy. Exclusion Criteria: Patients under the age of eighteen or who are pregnant will be excluded
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vivian von Gruenigen, MD
Organizational Affiliation
University Hospitals Cleveland Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals of Cleveland
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17400858
Citation
von Gruenigen VE, Gibbons HE, Gibbins K, Jenison EL, Hopkins MP. Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial. Obstet Gynecol. 2007 Apr;109(4):942-7. doi: 10.1097/01.AOG.0000258783.49564.5c.
Results Reference
derived

Learn more about this trial

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

We'll reach out to this number within 24 hrs